rosiglitazone has been researched along with Constriction, Pathologic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Jiamei, L; Jianhua, S; Liang, Y | 1 |
Chen, S; Dai, J; Hua, J; Mao, W; Qiu, Y; Xu, X; Zhou, X; Zhu, M | 1 |
Balakumar, P; Rose, M; Singh, M | 1 |
1 review(s) available for rosiglitazone and Constriction, Pathologic
Article | Year |
---|---|
Different Effects of Thiazolidinediones on In-Stent Restenosis and Target Lesion Revascularization after PCI: A Meta-Analysis of Randomized Controlled Trials.
Topics: Angioplasty, Balloon, Coronary; Constriction, Pathologic; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Humans; Myocardial Revascularization; Odds Ratio; Percutaneous Coronary Intervention; Pioglitazone; Randomized Controlled Trials as Topic; Risk Factors; Rosiglitazone; Stents; Thiazolidinediones; Treatment Outcome | 2017 |
2 other study(ies) available for rosiglitazone and Constriction, Pathologic
Article | Year |
---|---|
Molecular mechanism of benign biliary stricture inhibition by rosiglitazone-activated peroxisome proliferator-activated receptor gamma.
Topics: Animals; Collagen Type I; Connective Tissue Growth Factor; Constriction, Pathologic; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Transforming Growth Factors | 2022 |
Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
Topics: Analysis of Variance; Animals; Aorta, Abdominal; Blood Pressure; Cardiomegaly; Collagen; Constriction, Pathologic; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fenofibrate; Hypoglycemic Agents; Male; Myocardium; Myocytes, Cardiac; Organ Size; PPAR alpha; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Ventricular Function, Left | 2007 |